Progress of research on dyslipidemia accompanied by nephrotic syndrome
Nephrotic syndrome is a relatively common clinical disease. Associated dyslipidemia is a risk factor for the occurrence and development of cardiovascular and renal diseases that might gradually develop into atherosclerosis, glomerulosclerosis or tubulointerstitial injury. It also confers an elevated...
Main Authors: | Min Tao, Hai-Ping Wang, Jing Sun, Jing Tian |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-09-01
|
Series: | Chronic Diseases and Translational Medicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2095882X20300311 |
Similar Items
-
Paraoxonase Activity and Lipid Profile in Paediatric Nephrotic Syndrome: A Cross-sectional Study
by: Vijayetha P. Patil, et al.
Published: (2016-03-01) -
Impact of Τh1 and Τh2 cytokines in the progression of idiopathic nephrotic syndrome due to focal segmental glomerulosclerosis and minimal change disease
by: Maria Stangou, et al.
Published: (2017-07-01) -
Prevalence of pulmonary thromboembolism in nephrotic syndrome patients: A systematic review and meta-analysis
by: Abdullah Nasser Leslom, et al.
Published: (2020-01-01) -
Steroid-resistant nephrotic syndrome: past and current perspectives
by: Nourbakhsh N, et al.
Published: (2017-04-01) -
MicroRNAs as Biomarkers for Nephrotic Syndrome
by: Kenji Tsuji, et al.
Published: (2020-12-01)